ASP Isotopes Inc. $ASPI Shares Bought by Rovida Investment Management Ltd

Posted by Brenda Bartman on Jun 1st, 2026

Rovida Investment Management Ltd grew its stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI – Free Report) by 28.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,100,000 shares of the company’s stock after acquiring an additional 900,000 shares during the period. ASP Isotopes comprises approximately 3.0% of Rovida Investment Management Ltd’s holdings, making the stock its 7th biggest position. Rovida Investment Management Ltd owned 3.70% of ASP Isotopes worth $21,894,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. Quantbot Technologies LP acquired a new position in ASP Isotopes during the 3rd quarter worth $34,000. BNP Paribas Financial Markets lifted its position in shares of ASP Isotopes by 84.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after buying an additional 2,548 shares during the last quarter. IFP Advisors Inc bought a new position in shares of ASP Isotopes in the 4th quarter worth about $48,000. Pictet Asset Management Holding SA bought a new position in shares of ASP Isotopes in the 4th quarter worth about $61,000. Finally, Close Asset Management Ltd bought a new position in shares of ASP Isotopes in the 3rd quarter worth about $72,000. 16.80% of the stock is owned by institutional investors and hedge funds.

ASP Isotopes Stock Performance

ASP Isotopes stock opened at $7.78 on Monday. The company has a quick ratio of 4.37, a current ratio of 4.39 and a debt-to-equity ratio of 0.69. The firm has a 50-day moving average price of $5.23 and a two-hundred day moving average price of $5.88. The firm has a market capitalization of $979.50 million, a price-to-earnings ratio of -3.74 and a beta of 3.42. ASP Isotopes Inc. has a 52-week low of $3.92 and a 52-week high of $14.49.

ASP Isotopes (NASDAQ:ASPI – Get Free Report) last posted its earnings results on Wednesday, May 20th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.28) by $0.06. The firm had revenue of $8.36 million during the quarter, compared to analyst estimates of $3.68 million. ASP Isotopes had a negative net margin of 644.40% and a negative return on equity of 112.46%.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a research report on Friday, March 27th. Canaccord Genuity Group restated a “buy” rating and issued a $11.00 price target on shares of ASP Isotopes in a research report on Tuesday, April 14th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $13.00.

Get Our Latest Research Report on ASP Isotopes

Insider Buying and Selling at ASP Isotopes

In other ASP Isotopes news, Director Duncan Moore sold 11,642 shares of the business’s stock in a transaction dated Thursday, April 16th. The shares were sold at an average price of $5.21, for a total transaction of $60,654.82. Following the completion of the transaction, the director directly owned 1,044,928 shares of the company’s stock, valued at $5,444,074.88. The trade was a 1.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Heather Kiessling sold 23,124 shares of the business’s stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $5.48, for a total transaction of $126,719.52. Following the transaction, the chief financial officer directly owned 709,376 shares of the company’s stock, valued at $3,887,380.48. The trade was a 3.16% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 90,704 shares of company stock valued at $463,252 in the last ninety days. Company insiders own 14.40% of the company’s stock.

ASP Isotopes Profile

(Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.